Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diethylstilbestrol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 13/20 | 0.64 |
| ▸ | ESR2 | Q92731 | 9/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | FYN | P06241 | 1/20 | 0.64 |
| ▸ | PGR | P06401 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5493820 | 0.85 | CYP1A2 (0.71) | ESR1ESR2LMNACYP1A2PTGS2 | |
| SCHEMBL23727875 | 0.85 | CYP1A2 (0.71) | ESR1ESR2LMNACYP1A2PTGS2 | |
| Diethylstilbestrol SCHEMBL27649015 | 0.85 | ESR1 (0.82) | ESR1ESR2LMNACYP1A2PTGS2 | |
| Diethylstilbestrol SCHEMBL27375279 | 0.84 | ESR1 (0.90) | ESR1ESR2LMNACYP1A2PTGS2 | |
| Hydroquinone SCHEMBL51561 | 0.82 | TSHR (0.79) | LMNACYP1A2PTGS2TSHRPTGS1 | |
| Hydroquinone SCHEMBL11209736 | 0.81 | TSHR (0.62) | ESR1ESR2LMNACYP1A2PTGS2 | |
| Diethylstilbestrol SCHEMBL27625811 | 0.81 | ESR1 (0.75) | ESR1ESR2LMNACYP1A2PTGS2 | |
| SCHEMBL1840533 | 0.80 | TSHR (0.75) | ESR1ESR2LMNACYP1A2PTGS2 | |
| Hydroquinone SCHEMBL7511716 | 0.80 | TSHR (0.75) | LMNACYP1A2PTGS2TSHRPTGS1 | |
| Diethylstilbestrol SCHEMBL9223 | 0.80 | ESR1 (1.00) | ESR1ESR2LMNACYP1A2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-20070042040-A1 | Methods and compositions using gonadotropin hormone releasing hormone | DEBIOPHARM S.A. (CH) | 2007-02-22 | — | — | US | claimed |
| EP-1617859-A1 | METHODS AND COMPOSITIONS USING GONADOTROPIN HORMONE RELEASING HORMONE | DEBIOPHARM S.A. (CH) | 2006-01-25 | — | — | EP | claimed |
| WO-2004096259-A1 | METHODS AND COMPOSITIONS USING GONADOTROPIN HORMONE RELEASING HORMONE | DEBIOPHARM S.A. (CH) | 2004-11-11 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | disclosed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | disclosed |
| US-20070042040-A1 | Methods and compositions using gonadotropin hormone releasing hormone | DEBIOPHARM S.A. (CH) | 2007-02-22 | — | — | US | disclosed |
| EP-1617859-A1 | METHODS AND COMPOSITIONS USING GONADOTROPIN HORMONE RELEASING HORMONE | DEBIOPHARM S.A. (CH) | 2006-01-25 | — | — | EP | disclosed |
| WO-2004096259-A1 | METHODS AND COMPOSITIONS USING GONADOTROPIN HORMONE RELEASING HORMONE | DEBIOPHARM S.A. (CH) | 2004-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | ESR1 1524/4885ESR2 409/4885LMNA 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.